期刊文献+

经导管肝动脉化疗栓塞术联合伽玛刀和射频热疗治疗原发性肝癌56例分析 被引量:6

Treatment of primary hepatic cancer with transcatheter arterial chemoembolization combined with γ-knife and radiofrequency hyperthermia:an analysis of 56 cases
暂未订购
导出
摘要 目的:探讨经导管肝动脉化疗栓塞术(TACE)联合伽玛刀和射频热疗治疗原发性肝癌的临床价值。方法:56例原发性肝癌患者均先行TACE治疗1次,1周后应用体部伽玛刀治疗(中位剂量35Gy),同时配合射频热疗4~6次;其中有35例患者治疗结束2~3周后进行了第2次TACE治疗。随访终点为治疗结束后2年或患者死亡。结果:患者1、2年生存率分别为75.0%(42/56)和48.2%(27/56)。结论:TACE联合伽玛刀和射频热疗治疗原发性肝癌疗效确切、安全性较好,值得临床进一步探索。 Objective To investigate the clinical effect of transcatheter arterial chemoembolization (TACE) combined with γ-knife and radiofrequency hyperthermia in the treatment of primary hepatic cancer. Methods Fifty-six patients with primary hepatic cancer were studied. Whole body-γ-knife (stereotaetic radiotherapy, media dose 35 Gy) was performed a week after a TACE. Radiofrequency hyperthermia was administered for 4 -6 times during the radiotherapy. Thirty-five patients underwent a second TACE 2 -3 weeks after the above treatment. Then patients were followed up for 2 years or patients death. Results The 1,2-year survival rates in the patients were 75% (42/56) ,48.2% (27/56) ,respectively. Conclusion TACE combined with γ-knife and radiofrequency hyperthermia is effective in the treatment of primary hepatic cancer, better security and deserves further investigation.
出处 《东南大学学报(医学版)》 CAS 2009年第6期519-521,共3页 Journal of Southeast University(Medical Science Edition)
关键词 原发性肝癌 经导管肝动脉化疗栓塞术 伽玛刀 放射疗法 射频热疗 primary hepatic cancer transcatheter arterial chemoembolization γ-knife radiotherapy radiofrequency hyperthermia
  • 相关文献

参考文献5

二级参考文献39

  • 1秦叔逵,陈洪,陈惠英,刘文虎,马军,潘其声.三氧化二砷诱导人肝癌细胞株凋亡的初步研究[J].临床肿瘤学杂志,1998,3(2):40-40. 被引量:48
  • 2夏廷毅,孙庆选,李平,于勇,崔纪青,范乃斌.体部γ-刀高分次剂量治疗Ⅰ~Ⅱ期非小细胞肺癌的临床研究[J].临床肿瘤学杂志,2005,10(1):20-24. 被引量:33
  • 3刘琳,赵伟,秦叔逵,李苏宜,邱少敏,王南瑶,陈惠英.三氧化二砷抗裸鼠人结肠癌移植瘤作用及其机制的研究[J].中国肿瘤临床,2005,32(18):1067-1070. 被引量:10
  • 4夏廷毅.全身γ-刀的现状及进展[A].第二届全国肿瘤靶向治疗技术大会暨首届立体定向放射治疗技术学术研讨会论文汇编[C].北京:2005.
  • 5Onishi H,Araki T,shirato H,et al.Stereotatic hypofractionated high-dose irradiation for stage I non-small-cell lung cancer:clinial outcomes in 245 subjects in a Japanese multiinstitutional study[J].Cancer.2004,101(7):1623-1631.
  • 6Martel MK,Ten Haken RK,Hazuka MB.Estimation of tumor control probability parameters from 3-D dose distributions of non-small-cell lung cancer patients[J].Lung Cancer,1999,24(1):31-37.
  • 7Fowler JF,chappell R.Non-small-cell lung tumors repopulate rapidly duringradiation therapy[J].Int J Radiat Oncol Biol Phys,2000,46(2):516-517.
  • 8Uematsu M,Shioda A,Tahara K,et al.Focal,high dose,and fractionated modified stereotactic radiation therapy for lung carcinoma patients[J].Cancer,1998,82(6):1062-1070.
  • 9Nagata Y,Negoro Y,Aoki T,et al.Clinical outcomes of 3-D conformal hypofrationated sigle high-dose radio therapy for one or two lung tumors using a stereotactic body frame[J].Int J Radial Oncol Biol Phys,2002,52(4):1041-1046.
  • 10Wulf J,Ulrich H,Ulrch O,et al.Hypofractionated,high-dose radiation under stereotactic conditions in the stereotactic body frame[J].Int J Radial Oncol Biol phys,1998,42(1):215.

共引文献51

同被引文献335

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部